353P Clinical outcomes of treatment with CDK4/6 inhibitors in metastatic breast cancer among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
| Autor: | Scheel, R., Choong, G.M., Koch, R., Yadav, S.K., Karki, A., Rao, R., Boddicker, N.J., Hu, C., Na, J., Kaggal, V., Murphy, S., Giridhar, K.V., Yasir, S., Goetz, M.P., Couch, F.J., Yadav, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S364-S364 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|